EP 1053351 A4 20020925 - NOVEL MOLECULES OF THE TNF RECEPTOR SUPERFAMILY AND USES THEREFOR
Title (en)
NOVEL MOLECULES OF THE TNF RECEPTOR SUPERFAMILY AND USES THEREFOR
Title (de)
NEUE MOLEKÜLE DER TNF-REZEPTORSUPERFAMILIE UND VERWENDUNGEN DAFÜR
Title (fr)
NOUVELLES MOLECULES DE LA SUPERFAMILLE DU RECEPTEUR DU FACTEUR DE NECROSE TUMORALE ET LEURS UTILISATIONS
Publication
Application
Priority
- US 9901679 W 19990127
- US 1419598 A 19980127
Abstract (en)
[origin: WO9937818A1] Novel STRIFE1 and STRIFE2 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length STRIFE1 and STRIFE2 proteins, the invention further provides isolated STRIFE1 and STRIFE2 fusion proteins, antigenic peptides and anti-STRIFE1 or STRIFE2 antibodies. The invention also provides STRIFE1 and STRIFE2 nucleic acid molecules, recombinant expression vectors containing nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a STRIFE1 or STRIFE2 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
IPC 1-7
C12Q 1/68; C12Q 1/02; C12P 21/06; C12N 5/00; A61K 31/00; A61K 38/00; C07K 1/00; C07K 16/00; C07H 21/04; A01K 67/027; C07K 14/705; C07K 14/715
IPC 8 full level
A01K 67/027 (2006.01); A61K 31/711 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 7/06 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C07K 16/30 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/53 (2006.01)
CPC (source: EP)
A61P 7/06 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); C07K 14/70578 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01)
Citation (search report)
- [E] WO 9913078 A1 19990318 - BIOGEN INC [US], et al
- [E] WO 9911791 A2 19990311 - UNIV WASHINGTON [US]
- [E] WO 9920644 A1 19990429 - GENETICS INST [US]
- [ED] EP 0990703 A1 20000405 - ONO PHARMACEUTICAL CO [JP]
- [E] WO 9933967 A2 19990708 - REGENERON PHARMA [US], et al
- [E] WO 9933980 A2 19990708 - CHIRON CORP [US]
- [X] DATABASE EMBL, EBI [online] XP002205784, Database accession no. AA003356
- See references of WO 9937818A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9937818 A1 19990729; AU 2472899 A 19990809; CA 2318743 A1 19990729; EP 1053351 A1 20001122; EP 1053351 A4 20020925; JP 2002528046 A 20020903
DOCDB simple family (application)
US 9901679 W 19990127; AU 2472899 A 19990127; CA 2318743 A 19990127; EP 99904304 A 19990127; JP 2000528724 A 19990127